Akiyuki Uzawa (A Uzawa)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Muscular Dystrophy

Tyrosine Kinase

Spectrum Disorder

Myasthenia Gravis

Top Venues

Journal of neurology, neurosurgery, and psychiatry

European journal of neurology

Clinical and experimental immunology

Annals of clinical and translational neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurology. Clinical practice 14 (3) (2024)
Akiyuki Uzawa, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Hideo Handa, Etsuko Ogaya, Yukiko Ozawa, Hiroki Masuda, Masahiro Mori, Satoshi Kuwabara
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis. Scandinavian journal of immunology 99 (5) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurology. Clinical practice 14 (3) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Kazuyuki Matsushita, Satoshi Kuwabara
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Frederike Cosima Oertel, Masahiro Mori, Friedemann Paul, Satoshi Kuwabara
NMOSD and MOGAD: an evolving disease spectrum. Nature reviews. Neurology (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry 95 (7) (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Satoshi Kuwabara
Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of neurology, neurosurgery, and psychiatry (2024)
Akiyuki Uzawa, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Hideo Handa, Etsuko Ogaya, Yukiko Ozawa, Hiroki Masuda, Masahiro Mori, Satoshi Kuwabara
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis. Scandinavian journal of immunology 99 (5) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology (2024)
Akiyuki Uzawa, Masahiro Mori, Hiroki Masuda, Mayumi Muto, Ryohei Ohtani, Shinji Aoyama, Kazuyuki Matsushita, Satoshi Kuwabara
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (8) (2024)
Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori P Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. Journal of neurology, neurosurgery, and psychiatry (2023)
Akiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Hiroyuki Akamine, Satoshi Kuwabara
Minimal symptom expression achievement over time in generalized myasthenia gravis. Acta neurologica Belgica (2023)
Yukiko Ozawa, Akiyuki Uzawa, Yosuke Onishi, Manato Yasuda, Yuta Kojima, Satoshi Kuwabara
Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies. Muscle & nerve (2023)
Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori P Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2023)
Manato Yasuda, Akiyuki Uzawa, Yukiko Ozawa, Yuta Kojima, Yosuke Onishi, Hiroyuki Akamine, Satoshi Kuwabara
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis. Scandinavian journal of immunology (2021)
Akiyuki Uzawa, Masahiro Mori, Satoshi Kuwabara
Different patterns of brainstem and cerebellar MRI abnormalities in demyelinating disorders with MOG and aquaporin-4 antibodies. Journal of neurology, neurosurgery, and psychiatry (2021)
Yukiko Ozawa, Akiyuki Uzawa, Manato Yasuda, Yuta Kojima, Yosuke Onishi, Fumiko Oda, Tetsuya Kanai, Keiichi Himuro, Naoki Kawaguchi, Satoshi Kuwabara
Long-term outcomes and prognostic factors in generalized myasthenia gravis. Journal of neurology 268 (10) (2021)
Yuta Kojima, Akiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Hiroyuki Akamine, Naoki Kawaguchi, Keiichi Himuro, Yu-Ichi Noto, Toshiki Mizuno, Satoshi Kuwabara
Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome. Journal of neurology, neurosurgery, and psychiatry 92 (9) (2021)
Hiroki Masuda, Masahiro Mori, Shigeki Hirano, Akiyuki Uzawa, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Reiji Aoki, Satoshi Kuwabara
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Journal of neurology, neurosurgery, and psychiatry (2021)
Akiyuki Uzawa, Y Kojima, Y Ozawa, M Yasuda, Y Onishi, H Akamine, N Kawaguchi, K Himuro, S Kuwabara
Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study. Clinical and experimental immunology 202 (3) (2020)
Yukiko Ozawa, Akiyuki Uzawa, M Yasuda, Yuta Kojima, F Oda, K Himuro, N Kawaguchi, S Kuwabara
Changes in serum complements and their regulators in generalized myasthenia gravis. European journal of neurology 28 (1) (2020)
Akiyuki Uzawa, S Kuwabara, Shigeaki Suzuki, T Imai, H Murai, Y Ozawa, M Yasuda, Y Nagane, K Utsugisawa
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clinical and experimental immunology 203 (3) (2020)
Akiyuki Uzawa, M Mori, H Masuda, R Ohtani, T Uchida, R Aoki, S Kuwabara
Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder. Clinical and experimental immunology 202 (2) (2020)
Hiroki Masuda, Masahiro Mori, S Hirano, Akiyuki Uzawa, T Uchida, Ryohei Ohtani, R Aoki, S Kuwabara
Comparison of brain atrophy in patients with multiple sclerosis treated with first- versus second-generation disease modifying therapy without clinical relapse. European journal of neurology 27 (10) (2020)
Yoichiro Nishida, Y K Takahashi, T Kanai, Y Nose, S Ishibashi, Nobuo Sanjo, Akiyuki Uzawa, F Oda, Y Ozawa, Satoshi Kuwabara, E Noguchi, S Suzuki, J Nakahara, Norihiro Suzuki, T Ogawa, K Yokoyama, N Hattori, S Konno, T Fujioka, N Kawaguchi, Y Hatanaka, M Sonoo, J Kaneko, M Ogino, K Nishiyama, K Nomura, T Yokota
Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. European journal of neurology 27 (1) (2019)
Akiyuki Uzawa, T Kanai, F Oda, Y Ozawa, M Yasuda, N Kawaguchi, K Himuro, I Yoshino, S Kuwabara
Frequency and features of myasthenia gravis developing after thymectomy. European journal of neurology 27 (1) (2019)
Akiyuki Uzawa, M Mori, H Masuda, R Ohtani, T Uchida, S Kuwabara
Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines. Clinical and experimental immunology 193 (1) (2018)